相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Laurie H. Sehn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice
Alessandro Broccou et al.
ONCOLOGIST (2019)
Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update
Bruce D. Cheson et al.
LEUKEMIA & LYMPHOMA (2016)
Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
Jeffrey L. Vacirca et al.
ANNALS OF HEMATOLOGY (2014)
Differences in incidence and trends of haematological malignancies in Japan and the United States
Dai Chihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Ken Ohmachi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Jonathan W. Friedberg
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2011)
Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
Yasuhiro Oki et al.
CANCER SCIENCE (2008)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma
K Tobinai et al.
ANNALS OF ONCOLOGY (2004)
分享论文
